Related Experiment Video
Updated: Jul 9, 2025

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Treatment-Naive Atrial Fibrillation: A Systematic
Waqas Ullah1, Drew Johnson1, Abhinav S Nair2
1Department of Cardiology, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania.
Catheter ablation significantly reduces atrial fibrillation (AF) recurrence compared to antiarrhythmic drugs (AADs) in treatment-naive patients. This study found ablation offers similar safety regarding major adverse events, stroke, and mortality.
Area of Science:
- Cardiology
- Electrophysiology
- Clinical Trials
Background:
- First-line therapy for treatment-naive atrial fibrillation (AF) remains debated.
- Comparing catheter ablation and antiarrhythmic drugs (AADs) is crucial for patient outcomes.
Conclusions:
- First-line catheter ablation is effective in lowering AF recurrence in treatment-naive patients.
- Catheter ablation demonstrates comparable safety to AADs concerning major adverse events, stroke, and mortality.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

